Table 1.
Baseline demographic and clinical features of breast cancer patients.
| GPC3 Expression | |||
|---|---|---|---|
| Characteristic: | Negative n = 220 (92.5%) | Positive n = 18 (7.5%) | p Value |
| Age: | |||
| ≤50 (n = 140, 58.8%) | 128 (91.4%) | 12 (8.6%) |
0.482 |
| >50 (n = 98, 41.2%) | 92 (93.9%) | 6 (6.1%) | |
| Histological subtype: | |||
| Invasive ductal carcinoma (n = 178, 74.8%) | 178 (100.0%) | 0 (0.0%) |
0.001 |
| Invasive lobular carcinoma (n = 21, 8.8%) | 21 (100.0%) | 0 (0.0%) | |
| Intraductal carcinoma (n = 14, 5.9%) | 8 (57.1%) | 6 (42.9%) | |
| Mucinous adenocarcinoma (n = 6, 2.5%) | 5 (83.3%) | 1 (16.7%) | |
| Paget’s disease (n = 11, 4.6%) | 0 (0.0%) | 11 (100.0%) | |
| Normal (n = 8, 3.4%) | 8 (100.0%) | 0 (0.0%) | |
| Histological grade: | |||
| I (n = 16, 7.0%) | 13 (81.3%) | 3 (18.7%) |
0.148 |
| II (n = 189, 82.2%) | 177 (93.7%) | 12 (6.3%) | |
| III (n = 25, 10.8%) | 22 (88.0%) | 3 (12.0%) | |
| Tumour size: | |||
| T1 (n = 40, 17.4%) | 35 (83.3%) | 7 (16.7%) |
0.067 |
| T2 (n = 139, 60.4%) | 131 (95.6%) | 6 (4.4%) | |
| T3 (n = 33, 14.4%) | 30 (90.9%) | 3 (9.1%) | |
| T4 (n = 18, 7.8%) | 16 (88.9%) | 2 (11.1%) | |
| Lymph node metastasis: | |||
| Negative (n = 164, 71.3%) | 151 (92.1%) | 13 (7.9%) |
0.929 |
| Positive (n = 66, 28.7%) | 61 (92.4%) | 5 (7.6%) | |
| Distant metastasis: | |||
| Negative (n = 230, 100.0%) | 212 (92.2%) | 18 (7.8%) | |
| Positive (n = 0, 0.0%) | 0 (0.0%) | 0 (0.0%) | N/A |